SecBot SecBot

HAE

HAEMONETICS CORP
NYSE· Surgical & Medical Instruments & Apparatus· Inc. MA· CIK 0000313143 Healthcare & Medical Devices
$121.34 −1.60 (−1.30%)
Nov 16 4:00 PM ET · prev $122.94
Market cap
$5.6B
Mid cap
Consensus
Buy
80% Buy or better · 15 analysts
Median target
🔒 Subscribers only
1 year
+63.3%
from $74.32 · Nov 17
30 days
+2.2%
from $118.73
52-week range
$52.24–127.42
−5% from high · low May 11
Avg volume 20D
683.8K
shares / day
Short interest
3.60M
≈7.9% of shares · +5.0%
Days to cover
6.3
at average volume
Insider net
−$101.1K
0 buyers · 1 seller · 12 mo
New fund stakes
3
Q3 2026 13F · 0 exits
Filing reports
13
analyzed by SecBot
SecBot read BULLISH 9 reports · 90 days
Balance 0 bearish · 5 bullish · 4 neutral oldest → newest, height = score
Avg score ·High conf. 6/9

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InsidersBEARISH

    1 insider sold $101.1K.

  • InstitutionsBULLISH

    Q3 2026: 31 added (3 new), 17 trimmed or exited. Largest new: Jane Street Group $34.2M.

  • AnalystsBULLISH

    12 of 15 rate it Buy or better.

  • Short sellersSTEADY

    Short interest +5.0% to 3.60M shares. 6.3 days to cover, ≈7.9% of shares.

  • TrendUPTREND

    7% above its 50-day average.

Who's buying

13F· Q3 2026
3
new positions
0
exits
$34.2M
in new stakes · top 1 shown
FundMoveSharesValue
ARROWSTREET CAPITAL, LIMITED PARTNERSHIPTRIM853,763$89.9M
FMR LLCADD504,825$53.2M
Assenagon Asset Management S.A.DOUBLED453,579$47.8M
FORT WASHINGTON INVESTMENT ADVISORS INC /OH/TRIM450,936$47.5M
Boston Trust Walden CorpTRIM385,355$40.6M
Allspring Global Investments Holdings, LLCTRIM362,967$37.9M
JANE STREET GROUP, LLCNEW324,498$34.2M
Boston PartnersTRIM262,305$27.5M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

15 analysts
Buy 80% rate it Buy or better
Strong Buy6Buy6Hold3Sell0Strong Sell0

Fresh Price Targets

Analyst price targets updated within the last 24 hours are for subscribers only.

Subscribe for Full Access
Recent actions
DateFirmActionRating
Nov 16, 2026🔒 Fresh data, subscribers only
MAINTAIN
MAINTAIN
Nov 13, 2026Jefferies
INITIATE
INITIATEBuy
Nov 6, 2026Citigroup
MAINTAIN
MAINTAINBuy
Nov 6, 2026Barrington Research
MAINTAIN
MAINTAINOutperform
Nov 5, 2026BTIG
MAINTAIN
MAINTAINBuy
Oct 9, 2026Barrington Research
MAINTAIN
MAINTAINOutperform

Insider ledger

Form 4
$0
bought · 0 insiders
$101.1K
sold · 1 insider
DateInsiderTypeValue
Nov 11, 2026
Maunsell Farris Maryanne
VP, Chief Accounting Officer
Nov 11, 2026
EXERCISE$95.2K
Nov 11, 2026
Maunsell Farris Maryanne
VP, Chief Accounting Officer
Nov 11, 2026
TAX W/H$208.8K
Nov 11, 2026
Maunsell Farris Maryanne
VP, Chief Accounting Officer
Nov 11, 2026
EXERCISE$61.7K
Nov 11, 2026
Maunsell Farris Maryanne
VP, Chief Accounting Officer
Nov 11, 2026
EXERCISE$30.4K
Nov 11, 2026
Maunsell Farris Maryanne
VP, Chief Accounting Officer
Nov 11, 2026
SELL$101.1K
Oct 30, 2026
Galvin Roy
EVP, Chief Commercial Officer
Oct 30, 2026
TAX W/H$17.5K
Jul 24, 2026
Pomeroy Claire
Director
Jul 24, 2026
AWARD2,538 sh
Jul 24, 2026
KROLL MARK W
Director
Jul 24, 2026
AWARD2,538 sh

Earnings setup

Estimates

Revision history: 🔒 Fresh data, subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data, subscribers only
Next Q🔒 Fresh data, subscribers only
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only

Short side

FINRA· Oct 30, 2026
3,599,250
shares short
+5.0%
vs prior settlement
6.3
days to cover
≈7.9%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Nov 12, 2026 SEC
Maryanne Maunsell Farris, an officer of Haemonetics, filed a Form 144 notice of intent to sell 836 shares of common…
144 · Impact 2/10
Nov 11, 2026 Insider
Maunsell Farris Maryanne acquired via exercise 1,068 shares
VP, Chief Accounting Officer @ $89.16 ($95.2K)
Nov 11, 2026 Insider
Maunsell Farris Maryanne surrendered for taxes 1,724 shares
VP, Chief Accounting Officer @ $121.10 ($208.8K)
Nov 11, 2026 Insider
Maunsell Farris Maryanne acquired via exercise 645 shares
VP, Chief Accounting Officer @ $95.73 ($61.7K)
Nov 5, 2026 SEC
Haemonetics reported Q2 fiscal 2027 revenue of $357.8M, up 9.3% YoY, and adjusted EPS of $1.35, beating the $1.29…
8-K · Impact 6/10
Nov 5, 2026 SEC
The company raised its full-year revenue guidance to $1.415B-$1.435B from $1.395B-$1.425B, reflecting confidence in…
PRESS-RELEASE · Impact 5/10
Nov 5, 2026 Earnings
Haemonetics Corporation Announces Second Quarter Fiscal 2027 Financial Results Available on Investor Relations Website
Financial release and supplemental presentation accessible online BOSTON, Nov. 5, 2026 /PRNewswire/
Oct 19, 2026 Press
Haemonetics received FDA approval for its PerQseal Elite vascular closure system for large-bore arterial procedures…
Impact 7/10
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent

SecBot reports

13 filings · 1 press release · 4 bullish · 0 bearish · 9 neutral
All HAE filing & press-release reports (14)